维普中文期刊产品整合服务
59篇 您的检索式:作者名="Veyradier"
    题名 作者 年代 出处 被引量
1Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thromhotic thrombocytopenic purpura:a study of ll cases显示文摘Fakhouri F Vemant JP Veyradier A 2005Blood JT Blood2005,106,:1
2Thrombotic thrombocytopenic purpura: from diagnosis to therapy显示文摘Eric Mariotte Agnès Veyradier 2015Current Opinion in Critical Care2015,,6:1
3Pathophysiology of thrombotic microangiopathies:Current understanding显示文摘Coppo P Veyradier A Durey MA 2002Ann Med Interne2002,153,3:1
4Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura显示文摘Coppo P Wolf M Veyradier A 2006Br J Haematol2006,132,1:1
5Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura:a study of 11cases显示文摘Fakhouri F Vernant JP Veyradier A 2005Blood2005,106,6:1
6Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies:a study of 111 cases显示文摘 Obert B Houllier A 2001Blood2001,98,6:1
7Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children显示文摘Loirat C Veyradier A Girma JP 2006Semin Thromb Hemost2006,32,2:1
8Ten candidate ADAMTS13 mutations in six French familieswith congenital thrombotic thrombocytopenic purpura (Up shaw-Schulman syndrome)显示文摘VEYRADIER A LAVERGNE JM RIBBA AS 2004J Thromb Haemost2004,2,:1
9Pathophysiology of thrombotic microangiopathies:current understanding显示文摘Coppo P Veyradier A Durey MA 2002Ann Med Intern(Paris)2002,153,3:1
10HLA-DRB1*11:a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians显示文摘Coppo P Busson M Veyradier A 2010J Thromb Haemost2010,8,:1
11Specific von WillebrandFactor-cleaving protease in thrombotic microangiopathies:a study of 111 cases显示文摘VEYRADIER A OBERT B HOULLIEU A 2001Blood2001,98,6:1
12Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases显示文摘Veyradier A Obert B Houlier A 2001Blood2001,98,:1
13Cancer-related thombotic microangiopathy secondary to yon Willebrand factorcleaving protease deficiency显示文摘Blot E Decaudin D Veyradier A 2002Thromb Res2002,106,2:1
14Specific vonWillebrand factor-cleaving protease in thrombotic microangiopathies:a study of111cases显示文摘Veyradier A Obert B Houllieu A 2001Blood2001,98,6:1
15Prothrombin 20210G/A mutation in two patients withmesenteric ischemia显示文摘Balian A Veyradier A Naveau S 0,,05:1
16Thrombotic thrombocytopenic purpura and its diagnosis 显示文摘Veyradier A Meyer D 2005J Thromb Haemost2005,3,11:1
17Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura:a study of 11 cases显示文摘Fakhouri F Vernant JP Veyradier A 2005Blood2005,106,6:1
18Specific Von Willebrand factor-cleaving proteasein thrombotic microangiopathies:a study of 111 cases 显示文摘Veyradier A Obert B Houllier A 2001Blood2001,98,:1
19Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura显示文摘 WOLF M VEYRADIER A el al 2006Rr J Haematol2006,132,1:1
20Pathophysiology of thrombotic micmangiopathies: current understanding 显示文摘Coppo P Veyradier A Durey MA 2002Ann Med Intern2002,153,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费